Flare <7062> announced consolidated financial results for the 2nd quarter (24/4/9) of the fiscal year ending 2025/3 on the 14th. Sales increased 30.6% from the same period last year to 3.569 billion yen, operating loss was 0.041 billion yen (profit of 0.052 billion yen for the same period last year), ordinary loss was 0.062 billion yen (profit of 0.05 billion yen), and interim net loss attributable to parent company shareholders was 0.065 billion yen (profit of 0.019 billion yen).
Sales of the massage direct management business were 1.995 billion yen (up 12.8 from the same period last year), and segment profit was 0.599 billion yen (up 14.4% from the same period). Treatment unit prices increased due to medical treatment fee revisions related to treatments for acupuncturists, massage therapists, and acupressure practitioners in 2024/6.
Sales of the massage franchise business were 0.473 billion yen (up 10.7% from the same period), and segment profit was 0.143 billion yen (up 46.0% from the same period). The number of new franchises established was 16, and the number of member stores at the end of the interim consolidated accounting period was 328 (7.2% increase from the same period).
Sales of the institutional nursing care service business were 0.886 billion yen (up 174.6% from the same period), and segment loss was 0.317 billion yen (loss of 0.158 billion yen in the same period last year). The number of bases is now 12. At existing facilities, the number of registered users increased due to the strengthening of sales activities to regional medical institutions, etc., and sales increased. Also, in the hospice business, the number of locations is now 7.
Sales from other businesses were 0.214 billion yen (up 0.2% from the same period), and segment profit was 0.014 billion yen (up 61.9% from the same period). By strengthening sales to regional medical institutions and care managers and promoting joint sales with massage directly managed business bases, the Group's service recognition activities were promoted.
Regarding the full-year consolidated earnings forecast for the fiscal year ending March 31, 2025, the initial plan for sales is 8.062 billion yen, up 41.2% from the previous fiscal year; operating income is 0.2 billion yen, up 81.2%; ordinary profit is down 37.1% to 0.079 billion yen; and net income attributable to parent company shareholders is 0.035 billion yen, down 38.5% from the same period.